Skip to main content

Advertisement

Log in

Antigens of infectious laryngotracheitis herpesvirus defined by monoclonal antibodies

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

Monoclonal antibodies to glycoprotein and protein antigens of infectious laryngotracheitis virus (ILTV) were divided into five groups on the basis of their reactivity in immunofluorescence and Western blotting. Group I antibodies recognised a single band of 60 k and Group II antibodies recognised bands of 205, 160, 115, 90 and 85 k in Western blotting. In immunofluorescence both these groups of antibodies reacted with antigens located in the cytoplasm of fixed virus-infected cells and they also reacted with unfixed cells, suggesting that these antigens are on the surface of virus-infected cells. While Group I monoclonal antibodies did not react with extracts of tunicamycin-treated cells, some Group II antibodies recognised bands of decreased molecular weight compared to those present in untreated cells. The reactivity of the Group II antibodies with extracts of tunicamycin-treated cells suggested that they recognised at least three different epitopes which was confirmed by ELISA additivity assays. Monoclonal antibodies of Group III, Group IV and Group V recognised several low molecular weight proteins from 45 to 24 k. Immunofluorescence studies showed that these were nuclear and cytoplasmic antigens that were not present on the surface of virus-infected cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arvin AM, Solem SM, Koropchak CM, Kinney-Thomas E, Paryani SG (1987) Humoral and cellular immunity to varicella-zoster virus glycoprotein gpI and to a non-glycosylated protein, p 170, in the strain 2 guinea pig. J Gen Virol 68: 2449–2454

    Google Scholar 

  2. Bagust TJ (1986) Laryngotracheitis (Gallid-1) herpesvirus infection in the chicken. 4. Latency establishment by wild and vaccine strains of ILT virus. Avian Pathol 15: 581–595

    Google Scholar 

  3. Beveridge WIB (1981) Animal health in Australia, vol 1, viral diseases of farm livestock. Australian Government Publishing Service, Canberra

    Google Scholar 

  4. Braun DK, Roizman B, Pereira L (1984) Characterization of post-translational products of herpes simplex virus gene 35 proteins binding to the surfaces of full capsids but not empty capsids. J Virol 49: 142–153

    Google Scholar 

  5. Cantin EM, Eberle R, Baldick JL, Moss B, Willey DE, Notkins AL, Openshaw H (1987) Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc Natl Acad Sci USA 84: 5908–5912

    Google Scholar 

  6. Cremer KJ, Mackett M, Wohlenberg C, Notkins AL, Moss B (1985) Vaccinia virus recombinant expressing herpes simplex virus type 1 gylcoprotein D prevents latent herpes in mice. Science 228: 737–740

    Google Scholar 

  7. Friedrichs WE, Grose C (1986) Varicella-zoster virus p 32/p 36 complex is present in both the viral capsid and the nuclear matrix of the infected cell. J Virol 57: 155–164

    Google Scholar 

  8. Friguet B, Djavadi-Ohaniance L, Pages J, Bussard A, Goldberg M (1983) A convenient enzyme-linked immunosorbent assay for testing whether monoclonal antibodies recognize the same antigenic site. Application to hybridomas specific for the β2-subunit ofEscherichia coli tryptophan synthase. J Immunol Methods 60: 351–358

    Google Scholar 

  9. Galfré G, Howe SC, Milstein C, Butcher GW, Howard JC (1977) Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266: 550–552

    Google Scholar 

  10. Hampl H, Ben-Porat T, Ehrlicher L, Habermehl K-O, Kaplan AS (1984) Characterization of the envelope proteins of pseudorabies virus. J Virol 52: 583–590

    Google Scholar 

  11. Hanson L (1984) Laryngotracheitis. In: Hofstad MS, Barnes HJ, Calnek BW, Reid WM, Yoder HW Jr (ed) Diseases of poultry, 8th edn. Iowa State University Press, Ames, Iowa, pp 444–451

    Google Scholar 

  12. Hughes CS, Jones RC, Gaskell RM, Jordan FTW, Bradbury JM (1987) Demonstration in live chickens to the carrier state in infectious laryngotracheitis. Res Vet Sci 42: 407–410

    Google Scholar 

  13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T 4. Nature 227: 680–685

    Google Scholar 

  14. La Thangue NB, Chan WL, Almeida JD (1984) Monoclonal antibodies to herpes simplex virus type 1 glycoproteins show that epitope location influences virus neutralization. J Med Virol 13: 227–242

    Google Scholar 

  15. McDermott MR, Graham FL, Hanke T, Johnson DC (1989) Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology 169: 244–247

    Google Scholar 

  16. McLean C, Buckmaster A, Hancock D, Buchan A, Fuller A, Minson A (1982) Monoclonal antibodies to three non-glycosylated antigens of herpes simplex virus type 2. J Gen Virol 63: 297–305

    Google Scholar 

  17. Martin S, Courtney RJ, Fowler G, Rouse BT (1988) Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins. J Virol 62: 2265–2273

    Google Scholar 

  18. Morgan AJ, Smith AR, Barker RN, Epstein MA (1984) A structural investigation of the Epstein-Barr (EB) virus membrane antigen glycoprotein, gp340. J Gen Virol 65: 397–404

    Google Scholar 

  19. Norrild B, Virtanen I, Pedersen B, Pereira L (1983) Requirements for transport of HSV-1 glycoproteins to the cell surface membrane of human fibroblasts and Vero cells. Arch Virol 77: 155–166

    Google Scholar 

  20. Paoletti E, Lipinskas BR, Samsonoff C, Mercer S, Panicali D (1984) Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proc Natl Acad Sci USA 81: 193–197

    Google Scholar 

  21. Reddehase MJ, Mutter W, Münch K, Bürhing H-J, Koszinowski UH (1987) CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 61: 3102–3108

    Google Scholar 

  22. Sjöblom I, Lundström M, Sjögren-Jansson E, Glorioso JC, Jeansson S, Olofsson S (1987) Demonstration and mapping of highly carbohydrate-dependent epitopes in the herpes simplex virus type 1-specified glycoprotein C. J Gen Virol 68: 545–554

    Google Scholar 

  23. Spear PG (1985) Glycoproteins specified by herpes simplex viruses. In: Roizman B (ed) The herpesviruses, vol 3. Plenum Press, New York, pp 315–356

    Google Scholar 

  24. Vafai A, Wroblewska Z, Wellish M, Green M, Gilden D (1984) Analysis of three late varicella-zoster virus proteins, a 125,000 molecular-weight protein and gp 1 and gp 3. J Virol 52: 953–959

    Google Scholar 

  25. van Drunen Littel-van den Hurk S, Babiuk LA (1986) Synthesis and processing of bovine herpesvirus 1 glycoproteins. J Virol 59: 401–410

    Google Scholar 

  26. van Drunen Littel-van den Hurk S, van den Hurk JV, Gilchrist JE, Misra V, Babiuk LA (1984) Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 135: 466–479

    Google Scholar 

  27. Wachsman M, Aurelian L, Smith CC, Lipinskas BR, Perkus ME, Paoletti E (1987) Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D. J Infect Dis 155: 1188–1197

    Google Scholar 

  28. Weigle KA, Grose C (1983) Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles. J Infect Dis 148: 630–638

    Google Scholar 

  29. Weir JP, Bennet M, Allen EM, Elkins KL, Martin S, Rouse BT (1989) Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. J Gen Virol 70: 2587–2594

    Google Scholar 

  30. York JJ, Fahey KJ (1988) Diagnosis of infectious laryngotracheitis using a monoclonal antibody ELISA. Avian Pathol 17: 173–182

    Google Scholar 

  31. York JJ, Fahey KJ (1990) Humoral and cell-mediated immune responses to the glycoproteins of infectious laryngotracheitis herpesvirus. Arch Virol 115: 289–297

    Google Scholar 

  32. York JJ, Sonza S, Fahey KJ (1987) Immunogenic glycoproteins of infectious laryngotracheitis herpesvirus. Virology 161: 340–347

    Google Scholar 

  33. York JJ, Young JG, Fahey KJ (1989) The appearance of viral antigen and antibody in the trachea of naive and vaccinated chickens infected with infectious larnygotracheitis virus. Avian Pathol 18: 643–658

    Google Scholar 

  34. Zweig M, Heilman CJ Jr., Rabin H, Hopkins RF III, Neubauer RH, Hampar B (1979) Production of monoclonal antibodies against nucleocapsid proteins of herpes simplex virus types 1 and 2. J Virol 32: 676–678

    Google Scholar 

  35. Zweig M, Heilman CJ Jr, Rabin H, Hampar B (1980) Shared antigenic determinants between two distinct classes of proteins in cells infected with herpes simplex virus. J Virol 35: 644–652

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

York, J.J., Sonza, S., Brandon, M.R. et al. Antigens of infectious laryngotracheitis herpesvirus defined by monoclonal antibodies. Archives of Virology 115, 147–162 (1990). https://doi.org/10.1007/BF01310527

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01310527

Keywords

Navigation